tumour necrosis factor
Twin-drug combo effectively shrinks lung cancers by blocking their “escape route”
April 4, 2018Research and Development Cancer, epidermal growth factor, lung cancer, pharma, tumour necrosis factor
A study conducted by researchers at UT Southwestern’s Simmons Cancer Center has revealed that a combination of two specific drug …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
